Autres langues PDS Biotechnology Corporation

Actions

PDSB

US70465T1079

Temps réel estimé Cboe BZX Autres places de cotation 20:19:53 18/04/2024			Varia. 5j.	Varia. 1 janv.
2,865 ^USD	+5,33 %		-14,69 %	-42,15 %

28/03	PDS BIOTECHNOLOGY CORPORATION : B. Riley toujours à l'achat	ZM
27/03	Empire Metals vise des étapes clés en Australie	AN

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results	28/03
Empire Metals targets key milestones in Australia	27/03
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results	27/03
PDS Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
North American Morning Briefing : Stocks Edge -2-	27/03
PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results	20/03
PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®	13/03
PDS Biotechnology : Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune® - Form 8-K	13/03
PDS Biotechnology Corporation Announces Publication of Preclinical Research	13/03
PDS Biotechnology Names Kirk Shepard as Chief Medical Officer	22/01
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer	22/01
PDS Biotechnology Corporation Announces Executive Changes	22/01
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference	16/01
PDS Biotechnology Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	05/12
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	04/12
Apyx Medical Names Matthew Hill as CFO	28/11
PDS Biotechnology Appoints Lars Boesgaard as Finance Chief	28/11
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer	28/11
Pds Biotech Announces CFO Changes	28/11
PDS Biotechnology Corporation Announces Resignation of Matthew Hill as Principal Financial Officer and Principal Accounting Officer, Effective December 1, 2023	28/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PDS Biotechnology Corporation

Actions

PDSB

US70465T1079

Autres langues

Filtres